Table 2: Baseline transcript levels (ΔCT) for subjects with MDD (N=32) and sex-, age-, race-matched ND controls (N=32)

From: Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy

GeneMDD mean (s.d.)CONTROL mean (s.d.)P-valueqCohen’s D
ADCY320.95 (2.07)21.31 (2.18)0.0120.0260.473
AMFR19.28 (0.87)19.27 (0.42)0.9950.9950.001
ASAH116.74 (2.45)16.88 (2.25)0.3520.5030.167
ATP11C19.22 (1.83)19.20 (2.17)0.9020.9490.022
CD5919.98 (0.65)19.89 (0.66)0.5500.6510.107
CDR220.60 (1.13)20.49 (0.65)0.5540.6520.106
CMAS22.41 (1.36)22.98 (0.69)0.0460.0840.367
DGKA16.69 (0.80)17.41 (0.75)0.0000.0030.730
FAM46A19.65 (2.27)19.96 (2.40)0.0050.0170.532
IGSF4A/CADM122.22 (3.07)23.05 (2.57)0.0020.0100.597
KIAA153918.22 (0.61)18.64 (0.45)0.0010.0090.625
MAF22.00 (2.31)22.08 (2.47)0.6370.7080.084
MARCKS16.85 (2.31)17.41 (2.22)0.0050.0170.533
NAGA17.63 (2.22)17.85 (2.30)0.0410.0830.376
PSME117.17 (0.75)17.55 (0.52)0.0080.0230.501
PTP4A320.79 (0.82)21.03 (0.62)0.1540.2570.258
RAPH121.73 (1.47)22.80 (0.54)<0.0010.0030.737
SLC4A117.08 (0.85)17.22 (0.85)0.4540.6060.134
TLR719.53 (2.36)19.89 (2.35)0.0090.0230.493
ZNF29123.55 (3.18)23.20 (3.20)0.1760.2700.253
  1. Abbreviations: MDD, major depressive disorder; ND, nondepressed. Bold entries represent significant results.